Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT06044337
What this trial is testing

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 306
Large-scale testing (Phase 3)Active Not RecruitingNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 450
Not applicableUnknownNCT04558814
What this trial is testing

Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage

Who this might be right for
Systemic Lupus Erythematosus
Assiut University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06581198
What this trial is testing

Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Novartis Pharmaceuticals 179
Post-approval studies (Phase 4)Study completedNCT02953821
What this trial is testing

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Lupus Erythematosus, Systemic
Mallinckrodt 172
Not applicableStudy completedNCT06757725
What this trial is testing

Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity

Who this might be right for
Systemic Lupus ErthematosusLupus GlomerulonephritisLupus Flare
Kasr El Aini Hospital 75
Early research (Phase 1)Study completedNCT01845740
What this trial is testing

Phase Ib Study of SC Milatuzumab in SLE

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic+2 more
Gilead Sciences 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04895696
What this trial is testing

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Beeline Medicines Corporation 248
Testing effectiveness (Phase 2)Study completedNCT01085097
What this trial is testing

Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Teva Branded Pharmaceutical Products R&D, Inc. 46
Testing effectiveness (Phase 2)Looking for participantsNCT07260877
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLE+2 more
Ventus Therapeutics U.S., Inc. 24
Testing effectiveness (Phase 2)Study completedNCT03371251
What this trial is testing

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

Who this might be right for
Systemic Lupus Erythematosus
Boston Pharmaceuticals 143
Testing effectiveness (Phase 2)Looking for participantsNCT05039619
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782450
What this trial is testing

Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisIdiopathic Inflammatory Myositis+1 more
Pfizer 54
Testing effectiveness (Phase 2)Looking for participantsNCT06675422
What this trial is testing

JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 20
Testing effectiveness (Phase 2)Study completedNCT03742037
What this trial is testing

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Viatris Innovation GmbH 427
Not applicableStudy completedNCT00342095
What this trial is testing

Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Environmental Health Sciences (NIEHS) 640
Not applicableStudy completedNCT07071220
What this trial is testing

Efficacy of Vitamin C Supplementation on Serum IL-6 Levels and Disease Activity in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Universitas Sriwijaya 38
Testing effectiveness (Phase 2)UnknownNCT05967520
What this trial is testing

JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Jemincare 48
Large-scale testing (Phase 3)Ended earlyNCT01714817
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 695
Not applicableStudy completedNCT02554474
What this trial is testing

OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory Arthritis

Who this might be right for
Joint DiseasesRheumatoid ArthritisSystemic Lupus Erythematosus
University of British Columbia 118
Next Page